Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS dementia complex: a review

P Portegies1

  • 1Department of Neurology, Academisch Medisch Centrum, Amsterdam, The Netherlands.

Journal of Acquired Immune Deficiency Syndromes
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subjecting acute ischemic stroke patients to continuous tube feeding and an intensive computerized protocol establishes tight glycemic control.

Neurocritical care·2009
Same author

[Medicinal treatment of Bell's palsy: effect of prednisolone not sufficiently demonstrated].

Nederlands tijdschrift voor geneeskunde·2008
Same author

EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults.

European journal of neurology·2008
Same author

[Pharmacological treatment of Bell's palsy: favourable effects of prednisolone-based therapy now demonstrated].

Nederlands tijdschrift voor geneeskunde·2008
Same author

[Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].

Nederlands tijdschrift voor geneeskunde·2008
Same author

[Arguments against the pharmacotherapy of Bells' palsy].

Nederlands tijdschrift voor geneeskunde·2005
Same journal

T lymphocyte homeostasis after HIV seroconversion.

Journal of acquired immune deficiency syndromes·1994
Same journal

Improved detection of HTLV-II antibody using a whole viral lysate-based EIA.

Journal of acquired immune deficiency syndromes·1994
Same journal

Changes in HIV risk behavior among French heterosexuals: patterns of sexual monogamy and condom use between 1988 and 1991.

Journal of acquired immune deficiency syndromes·1994
Same journal

HTLV-I-associated myelopathy in Venezuela.

Journal of acquired immune deficiency syndromes·1994
Same journal

Autoantibodies to nucleosomes in HIV-1-infected patients.

Journal of acquired immune deficiency syndromes·1994
Same journal

Seroprevalence of HIV-1 and syphilis antibodies in blood donors in Gonder, Ethiopia, 1989-1993.

Journal of acquired immune deficiency syndromes·1994
See all related articles

AIDS dementia complex (ADC) involves cognitive, motor, and behavioral issues in individuals with AIDS. Antiretroviral therapy offers a way to delay or lessen these debilitating symptoms.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Public Health

Background:

  • AIDS dementia complex (ADC) presents as a spectrum of neurological, motor, and behavioral impairments in individuals diagnosed with Acquired Immunodeficiency Syndrome (AIDS).
  • The prevalence of ADC is variable, and it can manifest at any disease stage, though it is more commonly observed in advanced Acquired Immunodeficiency Syndrome.
  • The progression and severity of ADC differ among patients, frequently exhibiting a worsening trend.

Purpose of the Study:

  • To review the clinical manifestations, prevalence, and pathogenic mechanisms of AIDS dementia complex (ADC).
  • To discuss the impact of human immunodeficiency virus (HIV) infection on neurological function.
  • To highlight the potential therapeutic benefits of antiretroviral therapy on ADC symptoms.

Main Methods:

Related Experiment Videos

  • Literature review of studies on AIDS dementia complex.
  • Analysis of clinical observations and research findings related to HIV and neurological complications.
  • Synthesis of information on proposed pathogenic mechanisms and treatment outcomes.

Main Results:

  • AIDS dementia complex is characterized by a range of cognitive, motor, and behavioral deficits in individuals with AIDS.
  • Proposed causes include HIV-induced cytokine release and direct neuronal damage by the virus.
  • Antiretroviral therapy has demonstrated efficacy in delaying the onset or reducing the severity of ADC.

Conclusions:

  • ADC is a significant neurological complication associated with AIDS, with diverse clinical presentations.
  • Understanding the pathogenesis of ADC is crucial for developing effective interventions.
  • Antiretroviral therapy represents a key strategy in managing and potentially preventing the neurological decline associated with HIV infection.